| Sample Classification | Characterization | Method Development / Validation |
| Re-folded Proteins from Pseudomonas inclusion bodies | Y | Y |
| Recombinant Glycoprotein | Y | Y |
| Chimeric Antibody | Y | Y |
| Virus-Like Particles (VLP) | Y | Y |
| Acid Inactivated Vaccinia Virus Particle | Y | Y |
| Clostridium Difficile Toxin | Y | Y |
| Fusion (Chimeric) Proteins | Y | Y |
| Recombinant Neuregulin | Y | Y |
| Monoclonal Antibody (mAb) | Y | Y |
| Recombinant Proteins | Y | Y |
| PEGylated Proteins (Lys) | Y | Y |
| Poly-lysine matrix incorporating Penicillin | Y | Y |
| Poly-lysine matrix incorporating Peptides | Y | Y |
| IgG Antibodies | Y | Y |
| IgM Antibodies | Y | Y |
| Multi-Peptide Therapeutics | Y | Y |
| G-Protein Coupled Receptor (GPCRs) | Y | Y |
| Botulinum Toxin | Y | Y |
| Cross-Linked Hemoglobin Product | Y | Y |
| Polyclonal Antibodies | Y | Y |
| Recombinant Human Plasma Protein(s) | Y | Y |
| Peptide(s) Formulated in Gelatin | Y | Y |
| Antibody Drug Conjugates | Y | Y |
| Protein Drug Conjugates | Y | Y |
| Antibody Peptide Conjugate | Y | Y |
| Complex Protein Oligomerization / Scaffolds | Y | Y |
| Peptide Crosslinking / Scaffolds | Y | Y |
| Biosimilars (Etanercept, Adalimumab, etc) | Y | Y |
| Bispecific Antibodies | Y | Y |
| Fc Fusion Proteins | Y | Y |
| Diabodies | Y | Y |
| Bone Morphogenic Protein (BMP) / Growth Factors | Y | Y |
| Interleukin / Cytokines | Y | Y |
| Interferon / Cytokines | Y | Y |
| Erythropoietin (EPO) | Y | N |
| Insulin-like growth factor (IGF) | Y | N |
| Transforming growth factor alpha(TGF-α) | Y | Y |
| Tumor necrosis factor-alpha(TNF-α) | Y | Y |
| Vascular endothelial growth factor (VEGF) | Y | Y |
| Glial cell line-derived neurotrophic factor (GDNF) | Y | N |
| Protein - Oral Delivery | Y | Y |
| Peptide - Oral Delivery | Y | Y |
| Collagen Type I | Y | Y |
| Collagen Type VII | Y | N |
| PEGylated Proteins ( Lys / Cys ) | Y | Y |
| IgG4 Products | Y | Y |
| Isolation F(ab')2 | Y | N |
| Adenovirus Vaccine Products | Y | N |
| HIV Recombinant Protein Vaccine | Y | N |
| RSV-F Recombinant Protein Vaccine | Y | N |
| Plant-Derived Recombinant Proteins | Y | Y |
| Glutaraldehyde Crosslinked Proteins | Y | N |
| Proteins w/ Glycosylphosphatidylinositol (GPI) Anchor | Y | N |
| Lecithin-cholesterol acyltransferase (LCAT) | Y | N |
| Bacculovirus Derived Recombinant Proteins | Y | N |
| Peptide (Liposomal) Products | Y | Y |
| Small Molecule (Liposomal) Products | Y | Y |
| H1N1 Recombinant Protein Vaccine | Y | N |
| Cross linked Hemoglobin Product(s) | Y | Y |
| Recombinant Compliment Factor H | Y | Y |
| Peptide Detection in Human Plasma | Y | Y |
| Human Anti-thrombin III (ATIII) | Y | N |
| Recombinant Human serum amyloid P component (SAP) | Y | N |
| Sialylated Intravenous Immunoglobulin (sIVIG) | Y | Y |
| Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) | Y | N |
| Human activated protein C (APC) | Y | N |
| Avastin (Bevacizumab) Biosimilar | Y | N |
| Enbrel (Etanercept) Biosimilar | Y | Y |
| Copaxone (Glatiramer acetate) Biosimilar | Y | Y |
| Humira (Adilimumab) Biosimilar | Y | Y |
| Remicade (Infliximab) Biosimilar | Y | N |
| Herceptin (Trastuzumab) Biosimilar | Y | Y |
| Rituxan (Rituximab) Biosimilar | Y | N |
| Neupogen (Filgrastim) Biosimilar | Y | Y |
| Epogen (Erythropoietin) Biosimilar | Y | N |
| Heparan Sulfate: Detection in Urine, CSF, Plasma | Y | Y |
| Single Chain Fragments (scFv) | Y | N |
| IgG2 Antibodies | Y | N |
| Human Acid Ceramidase (hAC) | Y | N |
| Corium Analysis | Y | N |
| Plasmid DNA Vaccines | Y | N |
Poster
Poster